The Opportunity

MDAC is a holding company that offers significant strategic and operational support through a world class value-creation team of proven professionals and executives

Medical products industry has entered into a phase of costly product development in the treatment of cardiac, stroke conditions, and orthopedic.

Major companies are interested in divesting themselves of previously developed medical devices that are established in slower growing but still profitable markets.

These “orphan products” have:
established credibility with the medical community as standard of care,
approval from regulatory bodies such as the US FDA, and,
predictable cash flow, undervalued assets, and limited cash requirements.

Financial buyers have become increasingly aggressive in pursuit of medical device assets attracted by desirable long term growth and cash flow dynamics.